Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?


OverviewForecastFinancialsChartTranscripts

Cognition Therapeutics Ownership Summary


Cognition Therapeutics is owned by 10.38% institutional investors, 0.54% insiders, and 89.08% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 14.84% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.43% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCognition Therapeutics10.38%0.54%89.08%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp6.00M14.84%$4.21M
Vanguard group1.15M3.40%$1.90M
Sigma planning614.49K1.52%$430.94K
Alyeska investment group500.00K1.48%$830.00K
Geode capital management244.77K0.73%$406.39K
American financial group205.00K0.61%$340.00K
Cm management200.00K0.49%$140.26K
Blackrock152.58K0.45%$253.28K
Kestra advisory services177.43K0.44%$124.43K
Blackrock funding, inc. /de156.04K0.39%$109.43K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp6.00M4.39%$4.21M
American financial group205.00K0.15%$340.00K
Cm management200.00K0.13%$140.26K
Fca corp /tx51.47K0.03%$85.44K
Sigma planning614.49K0.01%$430.94K
Castle wealth management43.38K0.01%$30.42K
Texas capital bank wealth management services55.40K0.01%$91.96K
Alyeska investment group500.00K0.00%$830.00K
Bridgeway capital management76.70K0.00%$127.32K
Bangor savings bank34.02K0.00%$23.86K

Top Buyers

HolderShares% AssetsChange
Bios capital management, lp6.00M4.39%6.00M
Sigma planning614.49K0.01%417.30K
Vanguard group1.15M-225.87K
Blackrock152.58K-96.76K
Geode capital management244.77K-59.57K

Top Sellers

HolderShares% AssetsChange
Awm investment company---650.00K
Timelo investment management---361.40K
Aigh capital management---300.77K
Hohimer wealth management---225.00K
Carlson capital l p---140.00K

New Positions

HolderShares% AssetsChangeValue
Bios capital management, lp6.00M4.39%6.00M$4.21M
Envestnet asset management30.00K-30.00K$49.80K
Citadel advisors26.95K-26.95K$44.74K
Bryn mawr capital management23.34K0.00%23.34K$16.37K
Raymond james financial17.50K-17.50K$12.27K

Sold Out

HolderChange
Jpmorgan chase-70.00
Fmr-101.00
Opal wealth advisors-500.00
Sandy spring bank-2.00K
Qube research-2.12K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202438-17.39%4,196,749-20.97%104.19%15-21.05%4-42.86%
Jun 30, 202446-5,310,353-25.11%153.56%19-24.00%7-12.50%
Mar 31, 20244627.78%7,090,800-0.89%213.70%2556.25%8300.00%
Dec 31, 2023365.88%7,154,6550.15%234.31%16128.57%2-60.00%
Sep 30, 2023343.03%7,143,6671.94%234.20%7-50.00%5-28.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.01M2.43%-
Vanguard Institutional Extnd Mkt Idx Tr200.58K0.48%-
Fidelity Extended Market Index189.47K0.46%-1.53K
Bridgeway Ultra-Small Company Market76.70K0.19%-
iShares Micro-Cap ETF73.59K0.18%-
BlackRock Extended Equity Market K64.70K0.16%-27.00
Extended Equity Market Fund K63.82K0.15%-879.00
Fidelity Total Market Index59.27K0.14%-
Fidelity Series Total Market Index45.43K0.11%-
NT Ext Equity Mkt Idx Fd - NL26.89K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 31, 2025Ricciardi Lisa CEO & PresidentBuy$30.00K
Mar 14, 2024Ricciardi Lisa CEO & PresidentBuy$9.97K
Nov 29, 2022RICHSTONE ELLEN B-Buy$26.55K
Nov 28, 2022Fletcher Aaron G.L.-Buy$4.96K
Nov 28, 2022Fletcher Aaron G.L.-Buy$5.23K

Insider Transactions Trends


DateBuySell
2025 Q11-
2024 Q2--
2024 Q11-
2023 Q4--
2023 Q2--

CGTX Ownership FAQ


Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 10.38%, followed by 0.54% insiders and 89.08% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 109.70%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 14.84%), Vanguard group (1.15M shares, 3.40%), and Sigma planning (614.49K shares, 1.52%). Together, they hold 19.77% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

Yes, BlackRock owns 0.45% of Cognition Therapeutics, totaling 152.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 253.28K$. In the last quarter, BlackRock increased its holdings by 96.76K shares, a 173.34% change.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.39% of its assets in 6M Cognition Therapeutics shares, valued at 4.21M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 2.43% of its total shares outstanding invested in 1.01M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools